Literature DB >> 7350201

Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.

D Rudman, M H Kutner, R K Chawla, M A Goldsmith.   

Abstract

Previous studies showed hyperre-sponsiveness to human growth hormone (hGH) in men with myotonic or limb girdle dystrophies (MMD or LGD). Because polyamines may mediate some actions of hGH, we have now investigated polyamine metabolism in these and other dystrophies. Under metabolic balance study conditions, serum and urine levels of putrescine (Pu), spermidine (Sd), spermine (Sm), and cadaverine (Cd) were measured in six normal men (36-44 yr), four men with MMD (38-44 yr), and three men with LGD (30-36 yr), before and during treatment with 0.532 U/kg body wt ((3/4)/d) of hGH. Daily balances of N, P, and K were also monitored. In the normal subjects, hGH did not influence elemental balances or serum and urine polyamines. In MMD, hGH caused significant retention of N, P, and K (P < 0.005). Basal levels of Sm and Cd were significantly elevated above normal (P < 0.005), and Pu, Sm, and Cd increased two- to fourfold above basal during hGH treatment (P < 0.005). In LGD, hGH also caused retention of N, P, and K. Basal levels of nearly all the polyamines (not serum Pu) were significantly above normal in serum and urine (P < 0.05). During hGH treatment, all four polyamines rose significantly above basal (P < 0.005). Serum and urine polyamine levels in five boys with Duchenne muscular dystrophy, age 8-13, did not differ from those in five age-matched normal boys. Skeletal muscle polyamines were measured in five men (31-40 yr) without muscle disease and in three men with LGD (30-38 yr). Average concentrations of Pu, Sd, Sm, and Cd were 46, 306, 548, and 61 nmol/g wet wt in LGD and 1, 121, 245, and 14 in the normal subjects, respectively (P < 0.05 in each instance). Polyamines were determined in skeletal muscle, liver, kidney, and brain of male mice with hereditary muscular dystrophy and in age- and sex-matched normal controls. Pu, Sd, Sm, and Cd levels were two to three times higher than normal in muscle, but did not differ in liver, kidney, and brain. Similar findings were made in male hamsters with hereditary dystrophy and in their controls. The abnormality in hamster muscle polyamines appeared between 1 and 6 wk of age and persisted or intensified until 30 wk. These data reveal abnormalities of polyamine metabolism in men with MMD, in men with LGD, and in mice or hamsters with hereditary muscular dystrophy. The polyamine disorder could be related to dystrophic patients' hyperresponsiveness to hGH.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350201      PMCID: PMC371343          DOI: 10.1172/JCI109664

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Measurement of putrescine, spermidine, and spermine in physiological fluids by use of an amino acid analyzer.

Authors:  L J Marton; D H Russell; C C Levy
Journal:  Clin Chem       Date:  1973-08       Impact factor: 8.327

2.  Effect of polyamines on a ribonuclease which hydrolyzes ribonucleic acid at uridylic acid residues.

Authors:  C C Levy; W E Mitch; M Schmukler
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

3.  Polyamines and the accumulation of RNA in mammalian systems.

Authors:  A Raina; J Jänne
Journal:  Fed Proc       Date:  1970 Jul-Aug

4.  Amine synthesis in regenerating rat liver: effect of hypophysectomy and growth hormone on ornithine decarboxylase.

Authors:  D H Russell; S H Snyder
Journal:  Endocrinology       Date:  1969-02       Impact factor: 4.736

Review 5.  Biosynthesis and metabolism of 1,4-diaminobutane, spermidine, spermine, and related amines.

Authors:  H Tabor; C W Tabor
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1972

6.  Changes in polyamine content of rat liver following hypophysectomy and treatment with growth hormone.

Authors:  J L Kostyo
Journal:  Biochem Biophys Res Commun       Date:  1966-04-19       Impact factor: 3.575

7.  Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.

Authors:  D Rudman; S B Chyatte; J H Patterson; G G Gerron; I O'Beirne; J Barlow; A Jordan; J S Shavin
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

8.  Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy.

Authors:  D Rudman; S B Chyatte; J H Patterson; G G Gerron; I O'Beirne; J Barlow; P Ahmann; A Jordan; R C Mosteller
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

9.  Metabolic effects of plasmin digests of human growth hormone in the rat and man.

Authors:  J B Mills; C R Reagan; D Rudman; J L Kostyo; P Zachariah; A E Wilhelmi
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Hyper-responsiveness of patients with limb-girdle dystrophy to human growth hormone.

Authors:  D Rudman; S B Chyatte; G G Gerron; I O'Beirne; J Barlow
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

View more
  2 in total

Review 1.  Skeletal Muscle Pathophysiology: The Emerging Role of Spermine Oxidase and Spermidine.

Authors:  Manuela Cervelli; Alessia Leonetti; Guglielmo Duranti; Stefania Sabatini; Roberta Ceci; Paolo Mariottini
Journal:  Med Sci (Basel)       Date:  2018-02-14

2.  Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing.

Authors:  Daniel J Wilkinson; Giovanny Rodriguez-Blanco; Warwick B Dunn; Bethan E Phillips; John P Williams; Paul L Greenhaff; Kenneth Smith; Iain J Gallagher; Philip J Atherton
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.